227 related articles for article (PubMed ID: 29636691)
1. TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg.
Liu JF; Li JX
Front Pharmacol; 2018; 9():279. PubMed ID: 29636691
[TBL] [Abstract][Full Text] [Related]
2. Trace amine-associated receptor 1 and drug abuse.
Wu R; Liu J; Li JX
Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572
[TBL] [Abstract][Full Text] [Related]
3. TAAR1 and Psychostimulant Addiction.
Liu J; Wu R; Li JX
Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
[TBL] [Abstract][Full Text] [Related]
4. Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term.
Blum K; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Thanos PK; Demetrovics Z; Febo M
J Reward Defic Syndr Addict Sci; 2016; 2(1):14-21. PubMed ID: 28317038
[TBL] [Abstract][Full Text] [Related]
5. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.
Liu JF; Seaman R; Siemian JN; Bhimani R; Johnson B; Zhang Y; Zhu Q; Hoener MC; Park J; Dietz DM; Li JX
Neuropsychopharmacology; 2018 Nov; 43(12):2435-2444. PubMed ID: 29472642
[TBL] [Abstract][Full Text] [Related]
6. Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats.
Siemian JN; Zhang Y; Li JX
Behav Pharmacol; 2017 Oct; 28(7):590-593. PubMed ID: 28704278
[TBL] [Abstract][Full Text] [Related]
7. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
8. Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D
Asif-Malik A; Hoener MC; Canales JJ
Sci Rep; 2017 Oct; 7(1):13901. PubMed ID: 29066851
[TBL] [Abstract][Full Text] [Related]
9. TAAR1 as an emerging target for the treatment of psychiatric disorders.
Liu J; Wu R; Li JX
Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
[TBL] [Abstract][Full Text] [Related]
10. Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine.
Sukhanov I; Dorofeikova M; Dolgorukova A; Dorotenko A; Gainetdinov RR
Front Pharmacol; 2018; 9():329. PubMed ID: 29681856
[TBL] [Abstract][Full Text] [Related]
11. Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward.
Moore CF; Sabino V; Cottone P
Front Pharmacol; 2018; 9():129. PubMed ID: 29535626
[TBL] [Abstract][Full Text] [Related]
12. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
[TBL] [Abstract][Full Text] [Related]
13. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
Pei Y; Asif-Malik A; Hoener M; Canales JJ
Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
Pei Y; Mortas P; Hoener MC; Canales JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
[TBL] [Abstract][Full Text] [Related]
15. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1.
Espinoza S; Ghisi V; Emanuele M; Leo D; Sukhanov I; Sotnikova TD; Chieregatti E; Gainetdinov RR
Neuropharmacology; 2015 Jun; 93():308-13. PubMed ID: 25721394
[TBL] [Abstract][Full Text] [Related]
16. Trace amine-associated receptor 1 is a modulator of the dopamine transporter.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2007 Apr; 321(1):128-36. PubMed ID: 17234899
[TBL] [Abstract][Full Text] [Related]
17. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
18. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.
Espinoza S; Lignani G; Caffino L; Maggi S; Sukhanov I; Leo D; Mus L; Emanuele M; Ronzitti G; Harmeier A; Medrihan L; Sotnikova TD; Chieregatti E; Hoener MC; Benfenati F; Tucci V; Fumagalli F; Gainetdinov RR
Neuropsychopharmacology; 2015 Aug; 40(9):2217-27. PubMed ID: 25749299
[TBL] [Abstract][Full Text] [Related]
19. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
Wu R; Li JX
CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine.
Schwartz MD; Palmerston JB; Lee DL; Hoener MC; Kilduff TS
Front Pharmacol; 2018; 9():35. PubMed ID: 29456505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
